479413-70-2
中文名称
AUDA
英文名称
AUDA
CAS
479413-70-2
分子式
C23H40N2O3
分子量
392.58
MOL 文件
479413-70-2.mol
更新日期
2026/01/03 09:43:38
479413-70-2 结构式
基本信息
中文别名
化合物AUDA12-(3-(金刚烷-1-基)脲基)十二酸
英文别名
AUDA12-(3-adamantan-1-yl-ureido)dodecanoic acid
12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid
Dodecanoic acid, 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-
物理化学性质
熔点114 °C(Solv: hexane (110-54-3))
沸点592.7±19.0 °C(Predicted)
密度1.09±0.1 g/cm3(Predicted)
储存条件Sealed in dry,Store in freezer, under -20°C
溶解度DMSO：加热至60℃时≥10mg/mL
酸度系数(pKa)4.78±0.10(Predicted)
形态粉末
颜色白色至米色
InChI1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28)/t18-,19+,20-,23-
InChIKeyXLGSEOAVLVTJDH-UKBVAGSOSA-N
SMILESOC(=O)CCCCCCCCCCCNC(=O)NC12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2
AUDA价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-108570 | AUDA AUDA | 479413-70-2 | 1 mg | 166元 |
| 2025/12/22 | HY-108570 | AUDA AUDA | 479413-70-2 | 10mM * 1mLin DMSO | 296元 |
| 2025/12/22 | HY-108570 | AUDA | 479413-70-2 | 5 mg | 343元 |
常见问题列表
生物活性
AUDA (compound 43) 是一种有效的 soluble epoxide hydrolase (sEH) 的抑制剂，对小鼠sEH和人sEH的IC50值分别为18 nM和69 nM。AUDA具有抗炎活性，可降低MMP-9、IL-1β、TNF-α 和 TGF-β。AUDA还可下调 Smad3 和 p38 信号通路。靶点
| Target | Value |
|
MMP-9
() | |
|
IL-1β
() | |
|
TNF-α
() | |
|
TGF-β
() | |
|
Smad3
() |
体外研究
AUDA (0.3-10 μg/mL; 48 hours) dose-dependently suppresses the proliferation of rat VSMCs exposed to PDGF.
AUDA (0.3-10 μg/mL; 30 min) dose-dependently upregulats COX-2 expression.
AUDA (10, 50 and 100 μM) augments the migratory ability of HCAECs in a dose-dependent manner.
AUDA significantly increases the adhesion ability of HCAECs.
Cell Proliferation Assay
| Cell Line: | Vascular smooth muscle cell (VSMC) |
| Concentration: | 0.3, 1, 3, 10 μg/mL |
| Incubation Time: | 48 hours |
| Result: | Dose-dependently suppressed the proliferation of rat VSMCs exposed to PDGF. |
Western Blot Analysis
| Cell Line: | VSMC |
| Concentration: | 1, 3, 10, 30 μg/mL |
| Incubation Time: | 30 min |
| Result: | Dose-dependently upregulated COX-2 expression. |
体内研究
AUDA (i.p.; 10 mg/kg; 14 days) reduces TNF-α, MMP-9 and IL-1β expression levels.
| Animal Model: | Male (wild-type) C57BL/6 mice (age, 4-6 weeks; weight, 18-20 g) |
| Dosage: | 10 mg/kg |
| Administration: | i.p.; 14 days |
| Result: | Reduced TNF-α, MMP-9 and IL-1β expression levels. |